Hosted by Unknown Host · 🇺🇸 US · EN-US · 85 episodes
Established thought leaders with verified media credentials.
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.
Unknown Host hosts Hopkins Biotech Podcast, a science show with 85 episodes published.
Sickle cell disease was once considered an incurable disease, until recently. A wide variety of gene therapies have now become available, allowing patients with sickle cell disease to now have futures once thought unimag
Roivant Pharma is reinventing the discovery, development, and commercialization of new medicines. Mayukh Sukhatme, M.D. was recently appointed to Roivant's board of directors and has served as Roivant’s President and Chi
Dr. Ignacio Guerrero-Ros is an immunologist turned scientific communicator and biotech media innovator. Currently, he is an Assistant Vice President at Russo Partners , providing public and investor relations services to
Carina Clingman, Ph.D., is the Founder and CEO of Recruitomics Consulting , a niche talent acquisition and talent strategy firm specializing in biotech startups. She recently founded The Collaboratory Career Hub to help
About this episode: David Dornan is the Chief Scientific Officer of Elevation Oncology , a clinical-stage biotech company developing targeted cancer therapeutics, with a focus on antibody drug conjugates. David brings to
Emily Gransky is the Vice President of Recruiting at RA Ventures (RAVen). RAVen is the early-stage venture arm of the multi-stage investment firm RA Capital . In this role, Emily works closely with senior leaders, ventur
Dr. Isaac Klein is the Chief Scientific Officer at Dewpoint Therapeutics . Dewpoint Therapeutics is leveraging condensate biology to impact a wide range of therapeutic targets across diverse disease areas. Armed with sig
Dr. Adam Jenkins is the Regional Site Director for the Massachusetts sites of Biolabs . BioLabs is an international, membership-based network of shared lab and office facilities located in key biotech innovation clusters
In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter for biotech deal-maki
Brian Culley is the CEO of Lineage Cell Therapeutics , a clinical-stage biotech company whose mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical con
In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter for biotech deal-maki
Adrian is an advisor for several biotech companies in Argentina. Before joining CITES , a venture builder from Argentina, he worked as an advisor for RedCrow VC in San Francisco, and has more than 10 years working in the
Cyclacel Pharmaceuticals is a clinical-stage, biopharmaceutical company, developing innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology with a focus on oncology and hematology
Radamés Cordero is the CEO of Melatech and an associate scientist and junior faculty in the department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health where he studies the biol
Ratio Therapeutics is a Boston-based pharmaceutical company with the mission to accelerate the development of best-in-class targeted radiotherapeutics for the treatment of cancers. By employing a suite of innovative tech
Dr. Anupam Chakravarty is a researcher whose research interests have straddled the disciplines of biochemistry and genomics with a keen focus on the biology of cancer. Currently, he is a senior scientist developing liqui
Dr. Tony Russo Ph.D. is the Chairman, CEO, and founder of Russo Partners , a leading public and investor relations firm. He has been a member of the healthcare and technology PR and IR community for more than three decad
Dr. Robert Hollingsworth is the current Chief Scientific Officer of Shoreline Biosciences , a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs)-
Dr. Shelley Ackerman is an Associate Director & Program Team Lead at Bolt Biotherapeutics . Bolt is a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting preci
Dr. James Coates is currently the Principal for Health & Human Performance at Decisive Point, an East coast venture capital firm that invests in and supports startups with deep tech and government use cases. James holds
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch Hopkins Biotech Podcast, visit https://www.buzzsprout.com/1108808 for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent science coverage.
Hopkins Biotech Podcast is hosted by Unknown Host. The show is categorised under science (life) and has published 85 episodes.
Hopkins Biotech Podcast has published 85 episodes.
Hopkins Biotech Podcast regularly covers science, life, business. It sits in the science category, with a life focus.
Hopkins Biotech Podcast is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Hopkins Biotech Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Hopkins Biotech Podcast average 42 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Hopkins Biotech Podcast's guest bar at 82/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 2 days ago.
